Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer

Hiroshi Kikuchi(Futures in Rehabilitation Management (United States)), Kyoko Hida(Sapporo University)
British Journal of Cancer
December 1, 2023
Cited by 10


Related Papers